PHARMACOECONOMICS and RATIONAL DRUG USEPHARMACOECONOMICS and RATIONAL DRUG USE

  DRAFT PROGRAM FOR 1DRAFT PROGRAM FOR 1stst ISPOR INTERNATIONAL ISPOR INTERNATIONAL

SUMMER SCHOOL SUMMER SCHOOL   

ISPOR SCP (TURKEY)ISPOR SCP (TURKEY)ANTALYA, APRIL 17-21, 2008ANTALYA, APRIL 17-21, 2008

Antalya was founded in the second century BC by a king of Pergamon (Bergama), Attalus II. He needed a harbour in the South and had to found a new city since all the other harbours were under (bought) Roman protection. The city fast outgrew the nearby Side in importance. In 67 Pompeius used it as a basis for his fight against pirates. In 130 emperor Hadrian visited the city, and for the occasion a great arch was erected. Hadrian improved the cities defences and made it the capital of a new province. In 1207 the Seljuks conquered the city, and used it as a winter residence. Murat II integrated it into the Ottoman empire in the late 14th century.

April 17 Thursday   Check in     18.00 Welcome; 20.00 Dinner       April 18 Friday   08.30 – 09.20: ISPOR SCP and Why do we need pharmacoeconomics and rational drug use?   09.20 – 10.10: General economics and health expenditures – TR   10.10 – 10.30: Coffee Break   10.30 – 11.20: Principles of pharmacoeconomics Academics   11.20 – 12.10: Pharmacoeconomics for decision makers Academics   12.10 – 13.30: Lunch   13.30 – 14.20: GSS and SGK in Turkey; next 2 years Government speaker   14.20 – 15.10: Principles of Rational drug use   15.10 – 15.30: Coffee Break   15.30 – 16.20: DRGs and payment systems   16.20 – 17.10: How to apply rational drug use in the new system: The role of generic drugs    

April 19 Saturday   08.30 – 09.20: Reference pricing and competition?/budget impact   09.20 – 10.10: Reimbursement systems across Europe   10.10 – 10.30: Coffee Break   10.30 – 11.20: Quality of life and patient reported outcomes   11.20 – 12.10: What are we paying for?   12.10 – 13.30: Lunch   13.30 – 14.20: Budget impact of new technologies   14.20 – 15.10: Why do we need real life data with local costs?   15.10 – 15.30: Coffee Break   15.30 – 16.20: Pharmacoeconomics alongside clinical trials   16.20 – 17.10: Modeling methods and why do we need modeling?    

April 20 Sunday   08.30 – 09.20: How does Social Security Agencies make a decision?   09.20 – 10.10: How to prepare a reimbursement file?   10.10 – 10.30: Coffee Break   10.30 – 11.20: What does it mean for the pharma sector 1? National Drug

Manufacturers   11.20 – 12.10: What does it mean for the pharma sector 2? Multinational Drug

Companies   12.10 – 13.30: Lunch   13.30 – 14.20: Workshop; Reimbursement File Preparation 1 14.20 – 15.10: Workshop; Reimbursement File Preparation 2   15.10 – 15.30: Coffee Break   15.30 – 16.30: Conclusion and statements of ISPOR SCP

The Worldwide Role ofGeneric Pharmaceuticals

Dr Jonathan D. Quick, DirectorEssential Drugs and Other Medicines - EDM

Health Technology and Pharmaceuticals ClusterWorld Health Organization

June, 1999

Effective Drug Regulation:

what can countries do?

Essential Drugs and Other Medicines DepartmentHealth Technology and Pharmaceuticals Cluster

World Health OrganizationMarch 1999

5900

16800

3160034375

83909

0

10000

20000

30000

40000

50000

60000

70000

80000

90000

DOLAR

BETA BLOKER SİMVASTATİN NİFEDİPİN PRAVASTATİN STENT

PharmacoeconomPharmacoeconomics: What is it and where is it ics: What is it and where is it going?going?JS McCombs, Am J Hip., 11: 1125, 1998JS McCombs, Am J Hip., 11: 1125, 1998

Gained years/cost dolarGained years/cost dolarGained years/cost dolarGained years/cost dolar

P =M X C

B

P= PerformansM= MotivationC= CompetenceB= Barriers

Old systemOld system New systemNew system

Patient needsPatient needsPatient needsPatient needs

Physicians’ desicionPhysicians’ desicion

Administrators’ Administrators’ applicatinapplicatin

Administrators’ Administrators’ desiciondesicion

Physicians’ applicationPhysicians’ application